Chardan Capital Markets analyst Gbola Amusa raised the price target on Immunovant (NASDAQ: IMVT) to $35.00 (from $30.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE